Posted 10/15/2023, 4:36:00 PM
EU regulators delay approval of Novavax COVID vaccine over questions on XBB variant shot
- EU regulators delay approval of Novavax's revised COVID vaccine
- European Medicines Agency requests more info from Novavax on XBB variant shot
- EMA has questions on potency of vaccine's latest version
- Seeking to ensure vaccine characteristics consistent across production sites
- Novavax working closely with EMA, awaiting recommendations
- EMA expected to decide on vaccine use this month
/cloudfront-us-east-2.images.arcpublishing.com/reuters/GHTDDZVPHVNBDFXQD27Y5KPIAY.jpg)